Navigation Links
LSUHSC research adds new info to improve pediatric dental sedation

New Orleans, LA -- Research led by Priyanshi Ritwik, DDS, MS, LSUHSC Associate Professor of Pediatric Dentistry at LSU Health Sciences Center New Orleans, reports important findings about side effects and how long they linger after discharge of common oral drugs used to sedate some children during dental procedures. The results of the study, published in the current issue of Anesthesia Progress, provide pediatric dentists and parents with new information on this previously little-investigated aspect of children's dental health care.

The prospective study, conducted at the LSU Health Sciences Center New Orleans School of Dentistry, compared the incidence and duration of side effects of meperidine and hydroxyzine versus midazolam alone at 8 and 24 hours after sedation. The researchers found that while most adverse reactions occurred within eight hours, some continued up to 24 hours. They noted that children sedated with meperidine and hydroxyzine experienced vomiting, but not those sedated with midazolam. Prolonged sleep at home was significantly higher in the children sedated with meperidine and hydroxyzine. Irritability was more common in the midazolam group in the first eight hours, declining thereafter, while the number of irritable children in the meperidine and hydroxyzine group increased in the 8- to 24-hour period. They also report that 50% of the children in both groups slept in the car on the way home. This is a potential risk for airway obstruction because while sleeping in a car seat, the child's head can tilt down to the chest. It has been found that children and infants sleeping in car safety seats have a significantly lower oxygen saturation. The research team recommends that parents bring another adult along to monitor and reposition the child's head if necessary on the drive home.

"It is critical to know the effects of these medications beyond the time spent by the child in the dental office, so that parents can be appropriately cautioned about the expected effects and how to distinguish them from any potential emergencies such as airway obstruction," says Dr. Ritwik.

The team also recommends that parents be educated about which medications can safely be used to manage postoperative pain and fever as well as how to use them correctly. Additionally since some children do not want to eat in the first eight hours after sedation, they advise that parents be informed to anticipate this and encouraged to support their child to take liquids to maintain hydration.

Other members of the LSUHSC research team included Linda T. Cao, DDS, and Robert J. Musselman, DDS, MSD, along with Ronald Curran, DDS. The researchers note that this is a small, preliminary study and that further research is needed. In the meantime, however, this study yields new information to improve the safety and comfort for children and their parents following dental care.


Contact: Leslie Capo
Louisiana State University Health Sciences Center

Related medicine news :

1. LSUHSC research finds HPV-related head & neck cancers rising, highest in middle-aged white men
2. LSUHSCs Tilton awarded prestigious Hower Award
3. LSUHSC research finding keys to future obesity & related diseases
4. LSUHSC research provides new drug target for Her-2 related breast cancer
5. LSUHSC research discoveries shed light on common STI
6. LSUHSC research reveals Rx target for HPV, Hep C and related cancers
7. 8th edition of LSUHSC facultys textbook published
8. LSUHSC paper judged best of the year
9. LSUHSCs Hollier one of few ever awarded coveted national lectureship
10. UCLA Brain Injury Research Center gets NCAA funding for research on sports concussions
11. NIH awards $20 million over 5 years to train next generation of global health researchers
Post Your Comments:
(Date:10/13/2017)... ... October 13, 2017 , ... As health professionals work to ... “patient engagement.” The patient is doing more than filling out a survey; in many ... is an increasing emphasis in health care and research on the importance of active ...
(Date:10/13/2017)... ... October 13, 2017 , ... PurhealthRX , a ... utilizing Purzorb™ technology. Applying the Purzorb™process to full spectrum CBD oil will revolutionize the ... a CBD form that can be easily incorporated into liquid products, while reducing costs ...
(Date:10/13/2017)... ... October 13, 2017 , ... Many families have long-term insurance ... care insurance companies have a waiver for care if the client has a cognitive ... the family pays for care, is often waived, so the benefits from their insurance ...
(Date:10/13/2017)... ... ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh, has released ... understood books in the Holy Scriptures, Revelation. The Book of Revelation paints a picture ... Many have tossed it off as mere rubbish, but Yisrayl Hawkins says that is ...
(Date:10/13/2017)... ... ... “America On The Brink”: the Christian history of the United States and ... of published author, William Nowers. Captain Nowers and his wife, Millie, have six ... years in the Navy. Following his career as a naval aviator and carrier ...
Breaking Medicine News(10 mins):
(Date:10/11/2017)... , Oct. 11, 2017  Caris Life Sciences ... on fulfilling the promise of precision medicine, today announced ... joined Caris, Precision Oncology Alliance™ (POA) as its 17 ... centers, the St. Jude Crosson Cancer Institute will help ... the use of tumor profiling, making cancer treatment more ...
(Date:10/7/2017)... , Oct. 6, 2017   Provista, a ... than $100 billion in purchasing power, today announced a ... information. The Newsroom is the online home ... trends, infographics, expert bios, news releases, slideshows and events. ... to a wealth of resources at their fingertips, viewers ...
(Date:10/2/2017)... 2, 2017 Diplomat Pharmacy, Inc. (NYSE: ... and Consulting, LLC , and named its founder as ... in Tennessee , will operate under ... EnvoyHealth,s service offerings for health care partners to include ... "In an interoperable world, technology delivers ...
Breaking Medicine Technology: